IMPORTANCE An association of clinical and subclinical hypothyroidism with mild cognitive impairment (MCI) has not been established.
chemically as a normal serum free thyroxine concentration in the presence of an elevated TSH concentration, has a controversial association with cognitive impairment. Although many investigators have reported positive associations between memory impairment and subclinical hypothyroidism, [3] [4] [5] [6] [7] others have reported better performance in some areas of cognitive function among patients with decreased thyroid function 8 or no association. [9] [10] [11] [12] [13] [14] [15] Similarly, the association between clinical hypothyroidism and cognitive impairment is controversial and has been an issue for debate. Some studies have reported a positive association, [16] [17] [18] [19] and others found no relationship. [20] [21] [22] [23] [24] This inconsistency in the association across studies could result from various reasons, including differing diagnostic criteria for cognitive impairment or hypothyroidism, measurement instruments, and small sample sizes. Moreover, none of the studies specifically looked for an association between hypothyroidism and mild cognitive impairment (MCI). The MCI phase of the cognitive trajectory from normal aging to dementia has minimal clinical features with none or minimal functional impairment and can be identified by the recently published National Institute on Aging and Alzheimer's Association criteria. [25] [26] [27] [28] [29] Currently approved treatments for AD (eg, cholinesterase inhibitors, memantine) do not provide a "cure" in fully symptomatic patients, partly because the treatments are administered too late in the disease process. Therefore, recognizing the earliest stage of the pathophysiologic process of cognitive impairment and understanding the etiologic association with thyroid dysfunction is important. Early interventions focused on treating the underlying sources of cognitive decline may improve cognition or at least prevent further progression. 27 The main objective of our study was to investigate the association of subclinical and clinical hypothyroidism (treated and untreated) with MCI in a population-based cohort of elderly persons from Olmsted County, Minnesota. We hypothesized that clinical and subclinical hypothyroidism are the important risk factors for MCI.
Methods

Study Sample
Our study was approved by the institutional review boards of Mayo Clinic and Olmsted County Medical Center. All individuals signed an informed consent form to participate in the study and only those who provided authorization to review their medical records for research purposes were included. Patients received financial compensation for their time. In 2004, the Mayo Clinic Olmsted Study of Aging (also known as the Alzheimer Disease Patient Registry) used the resources of the Rochester Epidemiology Project to establish a populationbased cohort of individuals aged 70 to 89 years on October 1, 2004 . The detailed study design and participant recruitment have been described in a previous report. 30 In brief, using Roch- 40 a medical history review, and a detailed neurologic examination. The final diagnosis of cognitive impairment in a domain was based on the consensus agreement between the evaluating physician, nurse, and neuropsychologist after considering other important information, such as educational level, occupation, visual impairment, and hearing deficiency. 41 The following published criteria were used to make the diagnosis of MCI: memory concern raised by the research participants during the nurse interview, by informants (Clinical Dementia Rating scale), coordinators, or examining physicians; impairment in 1 or more of the 4 cognitive domains from the cognitive battery; essentially normal functional activities from MCI were further divided into amnestic MCI if the memory domain was impaired and nonamnestic MCI if the memory domain was not impaired but at least 1 memory domain was impaired. Dementia was diagnosed based on Diagnostic and Statistical Manual (Fourth Edition) criteria. 43 Persons who did not meet criteria for MCI or dementia and performed within the normal cognitive range of the normative data for this community 39 were considered cognitively normal.
Ascertainment of Thyroid Dysfunction
Diagnosis of hypothyroidism and hyperthyroidism was ascertained from the medical record linkage system. 44 Participants with a documented diagnosis of clinical hypothyroidism without documented thyroid replacement therapy were characterized as having clinically overt hypothyroidism if they had a TSH level of 10 mIU/L or higher with a free thyroxine level less than 1.01 ng/dL (to convert to picomoles per liter, multiply by 12.871). 10 Participants were characterized as having subclinical hypothyroidism based on physician documentation in the medical record, a TSH level less than 10 mIU/L, free thyroxine level of 1.01 to 1.79 ng/dL, and no thyroxine replacement therapy. Participants with hyperthyroidism were excluded from the study; this was based on a physician's diagnosis of hyperthyroidism in the medical record and an abnormally low TSH level. All thyroid tests were performed as per Mayo Clinic laboratory protocols.
Ascertainment of Potential Confounders
Covariates ascertained by personal interview during the baseline evaluation included sex, age, years of education, depression, diabetes mellitus, hypertension, stroke or transient ischemic attack, and coronary artery disease (angina, myocardial infarction, and coronary revascularization or bypass graft). Selfreported different medical comorbidities were confirmed from the Mayo Clinic medical records linkage system. 44 Depression was assessed during the interview of participants using the Beck Depression Inventory. 47 Body mass index (calculated as weight in kilograms divided by height in meters squared) was measured at the baseline visit. Apolipoprotein E (APOE) genotyping was done for each participant using validated methods. 48 
Statistical Analysis
Descriptive characteristics for categorical variables were summarized as frequencies, and significance differences were evaluated using a χ 2 test. Continuous variables were summarized as median and interquartile range, and comparisons were made using the rank sum test. A multiple logistic regression model was used to examine the association of clinical and subclinical hypothyroidism with MCI. The association was modeled with and without the preidentified covariates of interest, and the model was stratified further according to sex and APOE ε4. We generated an overall model adjusted for age, years of education, sex, APOE ε4, depression, diabetes, hypertension, stroke, body mass index, and coronary artery disease and also examined interactions of sex and APOE ε4 with clinical and subclinical hypothyroidism. Linear regression models adjusted for age, years of education, sex, and APOE ε4 were also used to evaluate the association of hypothyroidism with the 4 cognitive domains (memory, language, visuospatial, and attention). All the calculated P values were unpaired and 2-tailed, and differences were considered statistically significant at P < .05. All analyses were performed using SAS, version 3 (SAS Institute, Inc).
Results
Study Sample
A total of 2050 participants were evaluated in person by study personnel. Of these, 122 were excluded: 67 had dementia at baseline, 14 had incomplete assessments, and 41 did not provide authorization to use their medical records in research. Of the remaining 1928 individuals, 24 were excluded because of hyperthyroidism at the time of evaluation.
Participant Characteristics
Of Because hypothyroidism is more frequent in women, 49, 50 we conducted a stratified analysis by sex to assess possible effect modification on the association between MCI and hypothyroidism. Table 2 presents the 2 models for the association between MCI and thyroid function in men and in women. None of the models showed significant associations of MCI with clinical or subclinical hypothyroidism. Stratified analysis by APOE ε4 also showed a nonsignificant association between MCI and the thyroid groups ( Table 2 ). The association of amnestic MCI and nonamnestic MCI with clinical and subclinical hypothy- 
Discussion
In this population-based cross-sectional study in elderly persons, we did not find any significant association of MCI with clinical and subclinical hypothyroidism after accounting for possible confounding factors and interactions. Our findings are consistent with those of previous studies that reported a lack of association between thyroid dysfunction and cognitive decline. [9] [10] [11] [12] [13] [14] [15] [20] [21] [22] [23] [24] Gussekloo et al 10 found no association between thyroid status and cognitive performance in either crosssectional or prospective study designs in a population-based cohort of individuals aged 85 years or older. Similarly, other investigators were unable to find any significant association of cognitive decline with subclinical hypothyroidism [9] [10] [11] [12] [13] [14] [15] and clinical hypothyroidism. [20] [21] [22] [23] [24] However, they did not specifically look for the association of hypothyroidism with MCI, a well-defined, earliest detectable clinical stage of cognitive impairment.
On the other hand, many studies have identified a positive association of cognitive decline with clinical hypothyroidism [16] [17] [18] 51 and subclinical hypothyroidism. 3, [5] [6] [7] However, unlike the present study, none of the previous studies evaluated the association of hypothyroidism with MCI. Cognitive decline and thyroid dysfunction are common in the elderly, 10 and a widely held view is that hypothyroidism is a reversible risk factor for cognitive impairment, even though several studies have shown no such association. Our population-based findings also argue against an association and suggest that neither clinical nor subclinical hypothyroidism is a risk factor for MCI. Similarly, we did not find any significant association with individual cognitive domains except for the borderline association of clinical hypothyroidism with reduced performance in the visuospatial skills domain; however, the clinical significance of this is unknown. This raises questions about the need for routine testing of thyroid function as a part of the diagnostic workup in patients with MCI . Because patients with dementia were excluded from our analysis, we are unable to comment on the association of clinical and subclinical hypothyroidism with dementia. We found no significant interaction of hypothyroidism (clinical and subclinical) with sex and APOE ε4. Our study has several strengths. It was large and population based, representing an upper-Midwest population, and may be generalizable to other populations represented in our study or to the US white population. 52 Because participants were randomly selected from the population, the risk of selection 
